arginyl-glycyl-aspartic acid has been researched along with Osteolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, CJ; Deng, H; Sprague, JE; Wadas, TJ; Weilbaecher, KN; Zheleznyak, A | 1 |
| Achilefu, S; Anderson, CJ; Kitaura, H; Sprague, JE; Teitelbaum, SL; Weilbaecher, KN; Ye, Y; Zou, W | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and Osteolysis
| Article | Year |
|---|---|
Targeting the alphavbeta3 integrin for small-animal PET/CT of osteolytic bone metastases.
Topics: Animals; Bone Neoplasms; Copper Radioisotopes; Diagnosis, Differential; Diphosphonates; Gene Expression Regulation, Neoplastic; Gene Products, tax; Humans; Leukemia, T-Cell; Mice; Multiple Myeloma; Oligopeptides; Osteoclasts; Osteolysis; Positron-Emission Tomography; Receptors, Vitronectin; Spine; Tail; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a 64Cu-labeled RGD peptide.
Topics: Animals; Biotin; Blotting, Western; Bone Marrow Cells; Copper Radioisotopes; Half-Life; Integrins; Macrophages; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Osteoclasts; Osteolysis; Parathyroid Hormone; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Vitronectin | 2007 |